Share Icon Health Study Area: Cardiovascular Disease Chevron Icon Health Study Area: Genitourinary For Patients Health Study Area: Lung Cancer Page Icon Phone Icon For Caregivers Health Study Area: AutoImmune Disease Health Study Area: Melanoma Location Icon Print YouTube Icon For Parents Health Study Area: Lung Cancer Print Created with Sketch. Help Icon Green Check Icon Search Icon Instagram Created with sketchtool. Direction Arrow Icon Error Icon For Parents Health Study Area: Blood Cancer Help Icon Health Study Area: NASH Gender Both Bookmark Icon Health Study Area: Melanoma Created with Sketch. Glossary Print Health Study Area: Blood Cancer Health Study Area: Genitourinary Health Study Area: Gastrointestinal Cancer Mobile Menu Icon Created with Sketch. Health Study Area: Cardiovascular Disease Health Study Area: Women's Cancer Communities Map Icon Created with Sketch. For Caregivers Health Study Area: Fibrosis Health Study Area: AutoImmune Disease FAQs Health Study Area: Head and Neck Cancer Created with Sketch. For Clinicians Chevron Right Icon Gender Female Health Study Area: Breast Cancer Direction Arrow Icon Gender Both Right Arrow Icon LinkedIn Icon Green Check Icon Gender Male Health Study Area: Fibrosis For Patients Twitter Icon Email Icon Facebook Icon Health Study Area: Gastrointestinal Cancer Health Study Area: Head and Neck Cancer For Clinicians External Link Icon

Menu

Search BMS Clinical Trials
BMS Active Not Yet Recruiting Study icon

Active, Not Recruiting

Trial ID CN009-1024  |   NCT06144697

A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants

Warning icon
Sorry, this study is no longer accepting new participants, but is still ongoing.
You may click the “Check if you qualify” button and answer a few questions about your health to find out if you might be a match to another study.
Check if you qualify

Summary

  • Phase 1
  • Male and Female Gender icon
  • 18-55
    Age Range
  • BMS Active Not Yet Recruiting Study icon
    Active, Not Recruiting

Overview

The purpose of this study is to evaluate safety, tolerability, drug and food effects on relative bioavailability of BMS-986465 and its active derivative BMS-986464 in healthy participants and healthy participants of Japanese ethnicity.

print Print
email Email

Key Eligibility Criteria

Inclusion Criteria

Inclusion Criteria Icon img
:
  • Healthy male and female (i e, women not of childbearing potential) participants
    1. Body Mass Index (BMI) of 18 to 32 kg^m2 and total body weight ≥ 50 kg
      1. Parts A, B, and D: Participants without restriction on ethnicity
        1. Part C: Participants of Japanese ethnicity (both biological parents are ethnically Japanese)

          Exclusion Criteria

          Exclusion Criteria Icon
          :
          • Clinically significant medical, psychiatric and/or sound social reason, as determined by the investigator
            1. Any major surgery within 3 months of study intervention administration
              1. Participation in another clinical trial concurrent with this study Note: Other protocol-defined inclusion/exclusion criteria apply
                Additional Information *

                Treatment Options

                Study Arms

                ASSIGNED INTERVENTION

                Study Arms

                Experimental: Part A: Single Ascending Dose (SAD) [BMS-986465 or placebo]

                ASSIGNED INTERVENTION
                • Drug: BMS-986465
                • Other: Placebo

                Study Arms

                Experimental: Part B: Multiple Ascending Dose (MAD) [BMS-986465 or placebo, Pegasys]

                ASSIGNED INTERVENTION

                Study Arms

                Experimental: Part C: MAD in Japanese ethnicity [BMS-986465 or placebo]

                ASSIGNED INTERVENTION
                • Drug: BMS-986465
                • Other: Placebo

                Study Arms

                Experimental: Part D: Food/Formulation/pH Effects [BMS-986465, Famotidine]

                ASSIGNED INTERVENTION

                Help us enhance your website experience! Share your feedback with our team at BMS Clinical Trials to improve yours and others’ experience. Thank you